Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Jun 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Heart of AI

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Fund commits to $350M dedicated LS investments

Dec 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biotech investors cap off record year in fundraising

Nov 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI could exacerbate inequalities if misapplied, healthcare sector warned

Oct 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The State of Venture

Sep 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

French AI strategy: Tech sector to receive over €2 bln in next 5 years

Oct 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The 2021 machine learning, AI, and data landscape

Nov 11
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI startups notched another big quarter in a record-breaking year for global funding, mega-rounds, unicorns, exits, and more.

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement